SREBF2-AS1 and bladder transitional cell carcinoma: For example, MAGI2-AS3, PLK1S1, RP11-500G10.1, RP11-57H14.4, RP5-842K24.2, RP11-875O11.1, MED14-AS1, and RP11-65F13.2 in BLCA, RP5-1180C10.2, RP11-66N24.3, and FGD5-AS1 in KIRC, RPL32P3, RP11-66N24.3, RP5-1180C10.2, and SNHG11 in KIRC, and RP11-875O11.1, RP5-842K24.2, MAGI2-AS3, and FGD5-AS1 in PRAD were identified as key lncRNAs in coexpression networks.